ROLE OF PSYCHEDELIC DRUGS IN MENTAL HEALTH CARE: A NARRATIVE REVIEW
Medicina academica integrativa. December 20, 2024 DOI: 10.47960/3029-3316.2024.2.1.15 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Narrative Mental health care Literature |
| Key findings | Psychedelics show potential for transformative mental health benefits, but safety concerns and methodological limitations in current research constrain their therapeutic integration. |
Abstract
Good mental health is foundational for individual and societal well-being, enabling resilience, personal growth, and active community engagement. Despite the availability of pharmacological and non-pharmacological treatments, many individuals experience partial or non-response, delayed therapeutic effects, and adverse side effects. Increasingly, individuals are exploring the use of psychedelics for self-guided psychotherapy beyond clinical settings, highlighting their potential for transformative mental health benefits. However, the definition and application of psychedelics vary across contexts, underscoring the need for nuanced understanding and cautious use. While earlier prohibition was driven by exaggerated perceptions of harm, modern evidence recognizes psychedelics as powerful substances capable of eliciting profound positive and negative outcomes. Safety remains a paramount concern, and current research is constrained by methodological limitations. Addressing these gaps is essential to advancing the therapeutic potential of psychedelics, ensuring their responsible integration into mental health care while mitigating risks. Keywords: psychedelic drugs, mental health care, psychedelic-assisted therapy